| Lymphoma |
28.8% |
| T-cell Lymphoma |
25.2% |
| Diffuse Large B-cell Lymphoma |
16.2% |
| Product Used For Unknown Indication |
9.5% |
| Peripheral T-cell Lymphoma Unspecified |
7.6% |
| B-cell Lymphoma |
3.3% |
| Acute Lymphocytic Leukaemia |
2.7% |
| Burkitt's Lymphoma |
1.3% |
| Drug Use For Unknown Indication |
1.1% |
| Prophylaxis |
0.9% |
| T-cell Type Acute Leukaemia |
0.8% |
| Anaplastic Large Cell Lymphoma T- And Null-cell Types |
0.6% |
| Non-hodgkin's Lymphoma |
0.5% |
| Infection Prophylaxis |
0.3% |
| Premedication |
0.3% |
| Chronic Lymphoid Leukemia |
0.3% |
| Non-hodgkin's Lymphoma Stage Iv |
0.3% |
| Oesophageal Cancer Metastatic |
0.3% |
| Salvage Therapy |
0.2% |
| Haematoma |
0.2% |
